ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

KALA KALA BIO Inc

5,91
-0,09 (-1,50%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
KALA BIO Inc KALA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,09 -1,50% 5,91 06:00:14
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,02 5,90 6,02 5,96 6,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:05EDGAR2Form 8-K - Current report
04/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202414:00GLOBEKALA BIO to Present at Jefferies Global Healthcare..
14/5/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:06EDGAR2Form 8-K - Current report
14/5/202422:05GLOBEKALA BIO Reports First Quarter 2024 Financial Results and..
29/3/202413:00GLOBEKALA BIO Reports Fourth Quarter and Full Year 2023 Financial..
04/3/202413:30EDGAR2Form 8-K - Current report
26/2/202414:00GLOBEKALA BIO to Present at TD Cowen 44th Annual Healthcare..
14/2/202419:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202414:00GLOBEKALA BIO to Present at Oppenheimer 34th Annual Healthcare..
19/1/202422:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202314:22EDGAR2Form 8-K - Current report
13/11/202314:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:05EDGAR2Form 8-K - Current report
13/11/202314:00GLOBEKALA BIO Reports Third Quarter 2023 Financial Results and..
18/10/202322:04EDGAR2Form SC 13D/A - General statement of acquisition of..
20/9/202322:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/9/202314:00GLOBEKALA BIO to Present at H.C. Wainwright 25th Annual Global..
04/8/202314:00GLOBEKALA BIO Reports Second Quarter 2023 Financial Results and..
02/8/202322:01EDGAR2Form 8-K - Current report
02/8/202322:01GLOBEKALA BIO to Participate in Upcoming Investor Conferences in..
02/8/202314:00GLOBEKala Pharmaceuticals Announces Name Change to KALA BIO
19/7/202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
23/6/202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..

Dernières Valeurs Consultées

Delayed Upgrade Clock